Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
Condition(s):Psychotic Disorders; SchizophreniaLast Updated:May 21, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Psychotic Disorders; SchizophreniaLast Updated:May 21, 2014Completed
Condition(s):HealthyLast Updated:October 18, 2010Completed
Condition(s):HealthyLast Updated:October 18, 2010Completed
Condition(s):Anxiety StateLast Updated:August 4, 2022Terminated
Condition(s):Bipolar DisorderLast Updated:June 14, 2018Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 13, 2024Completed
Condition(s):Huntington Disease; ChoreaLast Updated:February 9, 2024Completed
Condition(s):Acute SchizophreniaLast Updated:February 22, 2022Completed
Condition(s):AutismLast Updated:May 17, 2022Completed
Condition(s):SchizophreniaLast Updated:March 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.